Q32 Bio Inc. Annual Operating Income (Loss) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Q32 Bio Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2023.
  • Q32 Bio Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$18.8M, a 141% decline year-over-year.
  • Q32 Bio Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$131M, a 129% decline year-over-year.
  • Q32 Bio Inc. annual Operating Income (Loss) for 2023 was -$101M, a 23.9% increase from 2022.
  • Q32 Bio Inc. annual Operating Income (Loss) for 2022 was -$133M, a 38.9% decline from 2021.
  • Q32 Bio Inc. annual Operating Income (Loss) for 2021 was -$95.9M, a 26.3% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$101M +$31.9M +23.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 -$133M -$37.3M -38.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 -$95.9M +$34.3M +26.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 -$130M -$20.3M -18.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-23
2019 -$110M -$50M -83.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 -$59.9M -$30.3M -102% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 -$29.7M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.